Ocugen, INC. (OCGN) SEC Filings — 2025
26 SEC filings for Ocugen, INC. (OCGN) in 2025.
Filings
- Ocugen Reports Director/Officer Changes and Compensation — 8-K · Dec 18, 2025
- Ocugen's Losses Widen to $50.1M Amid Soaring R&D Costs — 10-Q · Nov 5, 2025
- Ocugen, Inc. Files 8-K on Financials — 8-K · Nov 5, 2025
- Ocugen Terminates Material Definitive Agreement — 8-K · Sep 18, 2025
- Ocugen Enters Material Definitive Agreement — 8-K · Sep 16, 2025
- Ocugen Enters Material Definitive Agreement — 8-K · Sep 5, 2025
- Ocugen, Inc. Enters Material Definitive Agreement — 8-K · Aug 11, 2025
- Ocugen's Q2 Net Loss Widens to $19.5M Amid R&D Push — 10-Q · Aug 4, 2025
- Ocugen Files 8-K on Financials — 8-K · Aug 1, 2025
- Ocugen Closes $100M Public Offering — 8-K · Jul 30, 2025
- Ocugen to Acquire Ocuphire Pharma for $100M — 8-K · Jul 29, 2025
- Ocugen Faces Delisting Notice — 8-K · Jul 1, 2025
- Ocugen, Inc. Files 8-K: Material Agreement & Financials — 8-K · Jun 23, 2025
- Ocugen, Inc. Files 8-K Report — 8-K · Jun 17, 2025
- Ocugen Files 8-K: Shareholder Vote, Other Events, Financials — 8-K · Jun 5, 2025
- Ocugen Files Q1 2025 10-Q Report — 10-Q · May 9, 2025
- Ocugen Files 8-K: Regulation FD & Financials — 8-K · May 1, 2025
- Ocugen Files Definitive Proxy Statement for 2025 Shareholder Meeting — DEF 14A · Apr 25, 2025
- Ocugen Reports Director/Officer Changes — 8-K · Apr 25, 2025
- Ocugen Files 8-K: Routine Update — 8-K · Apr 4, 2025
- Ocugen, INC. 10-K Filing — 10-K · Mar 5, 2025
- Ocugen, Inc. Files 8-K Reporting Other Events — 8-K · Mar 3, 2025
- Ocugen Files 8-K: Other Events & Financials — 8-K · Feb 12, 2025
- Ocugen Files 8-K/A Amendment — 8-K/A · Feb 7, 2025
- Ocugen Files 8-K: Other Events & Financials — 8-K · Jan 29, 2025
- Ocugen Faces Delisting Concerns — 8-K · Jan 3, 2025